canakinumab
novartis
['mds', 'canakinumab']
novel class of treatment for mds? study on canakinumab shows the wonderful dynamic of nuanced hypothesis and instruments, steps back and forth. still a lot to unfold. #ash22 wonderful session with and all 
@TheEBMT_Trainee co-chair. @TheEBMT CAR-T in Plasma Cell Disorders Committee chair. Hematology. Medicine. Science. Train. Think. Implement integral actuality.